Utilico Insights - Jacqueline Broers assesses why Vietnam could be the darling of Asia for investors. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 10,678.00
Bid: 10,688.00
Ask: 10,690.00
Change: 0.00 (0.00%)
Spread: 2.00 (0.019%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 10,678.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

3 Jul 2023 09:07

LONDON MARKET OPEN: Stocks start second half in green amid PMIs

(Alliance News) - European markets rose at Monday's open, kicking off the start of the second half on a positive note, boosted by strong trading in Asia and New York,

Read more
3 Jul 2023 08:42

TOP NEWS: AstraZeneca, Daiichi hail datopotamab lung cancer trial

(Alliance News) - AstraZeneca PLC and Tokyo-based partner Daiichi Sankyo Co Ltd on Monday announced that their investigational antibody drug conjugate Datopotamab deruxtecan showed positive results in an advanced non-small cell lung cancer trial.

Read more
3 Jul 2023 07:57

AstraZeneca reveals mixed interim findings in lung cancer trial

(Sharecast News) - AstraZeneca announced on Monday that datopotamab deruxtecan, or 'Dato-DXd', has shown promising results in a trial in patients with locally-advanced or metastatic non-small cell lung cancer (NSCLC) who had previously received at least one therapy.

Read more
28 Jun 2023 11:54

IN BRIEF: AstraZeneca invests USD400 million in reforestation

AstraZeneca PLC - Cambridge-based pharmaceutical company - Announces USD400 million investment in global AZ Forest programme, aiming to plant 50 million trees by the end of 2025 and 200 million trees by 2030. Projects are in Brazil, India, Vietnam, Ghana and Rwanda. The programme is focused on reforestation, biodiversity and community resilience and spans over 100,000 hectares worldwide.

Read more
28 Jun 2023 10:55

The high growth companies that could re-rate in a recession

STOXX 600 up 0.6%, techs among big gainers

*

Read more
27 Jun 2023 08:19

AstraZeneca's diabetes combination treatment approved in China

(Alliance News) - AstraZeneca PLC on Tuesday said its Xigduo XR combination treatment has received approval in China for type-2 diabetes.

Read more
26 Jun 2023 08:39

EU committee recommends expanded approval for AstraZeneca's Soliris

(Alliance News) - AstraZeneca PLC on Monday said Soliris has been recommended for marketing authorisation in the EU for expanded use in generalised myasthenia gravis, gMG.

Read more
22 Jun 2023 14:02

Novo Nordisk says EMA raised safety signal on drugs including semaglutide

Signal included drugs from Eli Lilly, AstraZeneca, Sanofi

*

Read more
22 Jun 2023 08:54

Novo Nordisk shares slip on EMA drug safety signal

COPENHAGEN, June 22 (Reuters) - Novo Nordisk said on Thursday the European Union's drug watchdog had last month raised a thyroid cancer safety signal for several of its drugs including semaglutide, the active ingredient in its popular diabetes and obesity drugs, Ozempic and Wegovy.

Read more
20 Jun 2023 08:33

Lab crunch: British science has nowhere to go

OXFORD, England, June 20 (Reuters) - For Ros Deegan, the thrill of raising $100 million to expand a biotech firm among the dreaming spires of Oxford was soon tempered: unable to find a bigger laboratory, she routinely had to work at home.

Read more
19 Jun 2023 17:09

London stocks lag as miners slip; AstraZeneca weighs

AstraZeneca down on report of China business spin off plan

*

Read more
19 Jun 2023 11:56

Adding equities on disinflation, short squeeze risk - TS Lombard

STOXX 600 down 0.6%

*

Read more
19 Jun 2023 10:50

China spin-off may allow AstraZeneca to avoid "regulatory clampdown"

(Alliance News) - The Financial Times reported on Monday that AstraZeneca PLC has drafted plans to separate its China business amid geopolitical tensions.

Read more
19 Jun 2023 10:48

More to come as bear capitulation drives recent risk rally

STOXX 600 down 0.5%

*

Read more
19 Jun 2023 09:28

AstraZeneca planning spinoff of China business - report

(Sharecast News) - AstraZeneca has reportedly drawn up plans to break out its China business and list it separately in Hong Kong as a way to shelter the company against mounting geopolitical tensions.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.